APRILIGEN Trademark

Trademark Overview


On Monday, October 7, 2024, a trademark application was filed for APRILIGEN with the United States Patent and Trademark Office. The USPTO has given the APRILIGEN trademark a serial number of 98788439. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 20, 2025. This trademark is owned by Apriligen, LLC. The APRILIGEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Gene therapy research
apriligen

General Information


Serial Number98788439
Word MarkAPRILIGEN
Filing DateMonday, October 7, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, May 20, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 20, 2025

Trademark Statements


Goods and ServicesGene therapy research

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, October 7, 2024
Primary Code042
First Use Anywhere DateFriday, January 31, 2020
First Use In Commerce DateFriday, January 31, 2020

Trademark Owner History


Party NameApriligen, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressGreenwich, CT 06830

Party NameApriligen, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressGreenwich, CT 06830

Trademark Events


Event DateEvent Description
Monday, October 7, 2024NEW APPLICATION ENTERED
Monday, April 21, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 22, 2025ASSIGNED TO EXAMINER
Tuesday, April 22, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 14, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 20, 2025PUBLISHED FOR OPPOSITION
Tuesday, May 20, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords


apriligen research therapy gene